VIGNAROLI, GIULIA
 Distribuzione geografica
Continente #
NA - Nord America 1.218
EU - Europa 760
AS - Asia 147
Continente sconosciuto - Info sul continente non disponibili 3
AF - Africa 1
SA - Sud America 1
Totale 2.130
Nazione #
US - Stati Uniti d'America 1.214
GB - Regno Unito 263
IE - Irlanda 157
CN - Cina 124
SE - Svezia 89
UA - Ucraina 79
IT - Italia 70
DE - Germania 33
FR - Francia 33
FI - Finlandia 18
BE - Belgio 12
TR - Turchia 9
IR - Iran 7
CA - Canada 4
ES - Italia 3
EU - Europa 3
IN - India 3
JP - Giappone 2
CH - Svizzera 1
CL - Cile 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
EG - Egitto 1
PH - Filippine 1
TH - Thailandia 1
Totale 2.130
Città #
Southend 227
Dublin 155
Menlo Park 152
Fairfield 145
Chandler 117
Woodbridge 101
Ashburn 85
Seattle 78
Wilmington 75
Jacksonville 68
Houston 63
Ann Arbor 59
Cambridge 56
Beijing 47
Siena 41
New York 30
Princeton 28
Nanjing 20
San Diego 13
Shanghai 13
Boardman 12
Brussels 12
Lancaster 11
Dearborn 9
Fremont 7
Izmir 7
London 7
Nanchang 7
Tianjin 7
Milan 6
Helsinki 5
Redwood City 5
Venezia 5
Düsseldorf 4
Jiaxing 4
San Mateo 4
Changchun 3
Hebei 3
Hefei 3
Jinan 3
San Francisco 3
Sesto San Giovanni 3
Shenyang 3
Acerra 2
Bangalore 2
Guangzhou 2
Manchester 2
Málaga 2
Ningbo 2
Norwalk 2
Philadelphia 2
Prescot 2
Toronto 2
Winnipeg 2
Auburn Hills 1
Bangkok 1
Brno 1
Cairo 1
Changsha 1
Chengdu 1
Edinburgh 1
Frascati 1
Kilburn 1
Kunming 1
Lanzhou 1
Madrid 1
Montevarchi 1
Nasugbu 1
Rockville 1
Tappahannock 1
Tokyo 1
Washington 1
Zanjan 1
Zhengzhou 1
Zurich 1
Totale 1.749
Nome #
Prodrugs of pyrazolo[3,4-d]pyrimidines: from library synthesis to evaluation as potential anticancer agents in an orthotopic glioblastoma model 261
CYP-dependent metabolism of antitumor pyrazolo[3,4-d]pyrimidine derivatives is characterized by an oxidative dechlorination reaction. 181
Pyrazolo[3,4-d]pyrimidine Prodrugs: Strategic Optimization of the Aqueous Solubility of Dual Src/Abl Inhibitors 174
Arylation of 2-Furyl 4-Fluorophenyl Ketone: an extension of Heck Chemistry towards Novel Integrase Inhibitors 170
Computational techniques are valuable tools for the discovery of protein-protein interaction inhibitors: the 14-3-3s case 161
Discovery of 14-3-3 Protein-Protein Interaction Inhibitors that Sensitize Multidrug-Resistant Cancer Cells to Doxorubicin and the Akt Inhibitor GSK690693 154
Design, synthesis, and biological evaluation of pyrazolo[3,4-d]pyrimidines active in vivo on the Bcr-Abl T315I mutant 152
null 137
Small molecules modulation of 14-3-3 protein–protein interactions 135
An alternative synthetic approach for the synthesis of biologically relevant 1,4-disubstituted pyrazolo[3,4-d]pyrimidines 125
A Versatile and Practical Synthesis toward the Development of Novel HIV-1 Integrase Inhibitors 124
Exploring the chemical space around the privileged pyrazolo[3,4-d]pyrimidine scaffold: toward novel allosteric inhibitors of T315I-mutated Abl. 118
Hit Recycling: Discovery of a Potent Carbonic Anhydrase Inhibitor by in Silico Target Fishing 112
AuNP Pyrazolo[3,4-d]pyrimidine Nanosystem in Combination with Radiotherapy against Glioblastoma 95
COMPOUNDS AND USES THEREOF 51
Totale 2.150
Categoria #
all - tutte 5.590
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.590


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019163 0 0 0 0 0 0 0 0 5 30 66 62
2019/2020456 55 16 29 65 37 36 40 52 41 44 17 24
2020/2021311 9 35 2 38 35 44 14 40 22 33 24 15
2021/2022225 27 33 5 7 7 7 14 4 5 35 32 49
2022/2023320 19 36 37 48 31 55 13 34 25 8 12 2
2023/2024241 8 5 19 17 9 78 90 15 0 0 0 0
Totale 2.150